Several criteria from this study support utility of coupling the urinary sCD163/creatinuria ratio and SLE-associated serological markers as LN biomarkers based on statistical analysis (e.g., logistic regression, correlation) and distinct associations with histological presentation, renal activity, and ESKD evolution. Here, CD163 is linked to systemic lupus erythematosus.